School of Medicine Distinguished Lecture Series featuring Todd W. Rice, MD, MSc

Fluid Management in Sepsis: Does What and How Much I Give Matter?

Wednesday, January 17, 2024
Noon-1:00 p.m. CST
11:00 a.m.-Noon MST

In-Person at:
CHI Health Creighton University
Medical Center Bergan Mercy
Room 11661A, B and C
7710 Mercy Road
Omaha, NE68124

Click Here to View Online
For those attending virtually, this program will be available through Zoom. Scroll down under Featured Activities to find the DLS activity.

No Cost | 1.0 CE Hours

Image

Todd W. Rice, MD, MSc
Vice-President for Clinical Trials Innovation and Operations

Professor of Medicine

Division of Allergy, Pulmonary, and Critical Care Medicine

Vanderbilt University Medical Center

Nashville, TN

Designed For

Physicians, physicians assistants, nurses, nurse practitioners, residents, fellows and students

Provided By

• Creighton University School of Medicine
• Creighton University Office of Continuing Education

Objectives

• Understand the data on balanced versus saline crystalloid administration in critically ill patients and those with sepsis
• Recognize the impact that timing on balanced versus saline crystalloid administration might have on patients with sepsis
• Comprehend recent evidence informing on conservative versus liberal approaches to fluid management in patients with sepsis

Presented by Todd W. Rice, MD, MSc

Dr. Rice is a summa cum laude graduate of the University of Notre Dame, where he earned a Bachelor of Science degree in Biological Sciences in 1993.  He graduated with his Doctor of Medicine degree in 1997 from the Indiana University School of Medicine, where he was elected to the Alpha Omega Alpha honor society after his third year.  Upon graduation from medical school, Dr. Rice stayed in Indianapolis and trained as a resident in Internal Medicine at the Indiana University School of Medicine from 1997-2000 and served as chief resident from 2000-2001.  In 2001, he moved to Nashville to complete fellowship training in pulmonary and critical care medicine at Vanderbilt, finishing in 2005.  While still a pulmonary and critical care fellow, Dr. Rice graduated from the Vanderbilt University School of Medicine with a Master of Science in Clinical Investigation degree. In July 2005, Dr. Rice joined the faculty of the Division of Allergy, Pulmonary, and Critical Care Medicine, where he was promoted to Associate Professor with tenure in the Department of Medicine in 2015 and full Professor in 2023.  He was also named Vice-President for Clinical Trials Innovation and Operations within the Vanderbilt Institute for Clinical Trial Research (VICTR) in July 2020.

Since 2015, Dr. Rice has overseen the medical intensive care unit at Vanderbilt University Adult Hospital, as medical director.  He is also the director of respiratory extracorporeal membrane oxygenation (ECMO) at Vanderbilt University Hospital and has served as the medical director of the Vanderbilt Human Research Protections Program since July of 2009.

As a physician scientist, Dr. Rice both practices clinically as an intensivist in the MICU at VUMC and conducts clinical research in critically ill patients. His overriding interest continues to be improving the clinical care and outcomes of critically ill patients.  He has advanced the care of critically ill patients worldwide through innumerous clinical trials in many disease states, including but not limited to sepsis, acute respiratory distress syndrome (ARDS), acute respiratory failure, and critical illness malnutrition. In addition to having his own National Institutes of Health (NIH) funding, continuously for the last two decades, he served as an investigator in the NHLBI funded ARDS Network from 2005 through 2012, where he designed and led three landmark trials. He is a founding member of the Pragmatic Critical Care Trials Research Group and since 2011 has spent considerable research time conducting large, pragmatic trials of comparative effectiveness research in critically ill patients as part of the Vanderbilt Learning Healthcare System.  Currently, he is the co-director of the Learning Healthcare Systems Platform in Vanderbilt’s Clinical and Translational Science Award (CTSA) and he also serves as the critical care PI for Vanderbilt’s NHLBI funded Prevention and Early Treatment of Acute Lung injury (PETAL) clinical center.

Education Credit

Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.

Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hour for nurses. Nurses should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement
In support of improving patient care, Creighton University Health Sciences Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.